Table 2.
Inputs for market share and drug costs in the base case
| Product type | Utilization (market share) distribution (%) | Plan cost per prescription (open access, without copay)
|
Contracted cost per prescriptionb | Prescriptions per therapy | |
|---|---|---|---|---|---|
| Unit costa | Units per prescriptiona | ||||
| Commercial payer | |||||
| Varenicline | 74.46 | $5.71 | 55.42 | $316.43 | 3 |
| Bupropion | 5.12 | $0.60 | 59.76 | $35.86 | 3 |
| NRT inhaler | 1.48 | $1.88 | 183.93 | $345.79 | 3 |
| NRT nasal spray | 0.46 | $8.34 | 46.24 | $385.67 | 3 |
| NRT gum | 3.41 | $0.26 | 135.33 | $35.19 | 3 |
| NRT lozenge | 1.07 | $0.35 | 120.10 | $42.04 | 4 |
| NRT patch | 14.00 | $1.69 | 25.23 | $42.63 | 5 |
| Medicaid payer | |||||
| Varenicline | 40.72 | $5.74 | 53.94 | $309.63 | 3 |
| Bupropion | 3.63 | $0.57 | 54.85 | $31.27 | 3 |
| NRT inhaler | 1.59 | $1.88 | 175.43 | $329.81 | 3 |
| NRT nasal spray | 0.22 | $8.32 | 41.30 | $343.65 | 3 |
| NRT gum | 15.12 | $0.25 | 129.96 | $32.49 | 3 |
| NRT lozenge | 3.24 | $0.37 | 117.12 | $43.34 | 4 |
| NRT patch | 35.48 | $1.74 | 23.83 | $41.46 | 5 |
| Medicare payer | |||||
| Varenicline | 81.76 | $5.73 | 56.32 | $322.69 | 3 |
| Bupropion | 8.25 | $0.56 | 68.24 | $38.22 | 3 |
| NRT inhaler | 4.10 | $1.87 | 190.67 | $356.56 | 3 |
| NRT nasal spray | 1.65 | $8.29 | 51.19 | $424.38 | 3 |
| NRT gum | 0.84 | $0.29 | 133.16 | $38.62 | 3 |
| NRT lozenge | 0.28 | $0.39 | 116.01 | $45.24 | 4 |
| NRT patch | 3.13 | $1.89 | 24.48 | $46.26 | 5 |
Notes:
a
Drug unit cost and units per prescription were derived from IQVIA National Prescription Audit™ (NPA) data.
b
Contracted cost per prescription was calculated as (Unit Cost × Units per Prescription − Patient Copay).
Abbreviation: NRT, nicotine replacement therapy.